StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
26
Publishing Date
2022 - 09 - 20
1
2022 - 09 - 06
1
2022 - 08 - 12
1
2022 - 06 - 29
1
2022 - 06 - 09
1
2022 - 04 - 19
1
2022 - 04 - 14
1
2022 - 04 - 12
1
2022 - 04 - 01
1
2022 - 03 - 11
1
2022 - 02 - 07
1
2022 - 01 - 31
1
2022 - 01 - 04
1
2021 - 12 - 21
1
2021 - 12 - 08
1
2021 - 11 - 30
1
2021 - 11 - 16
1
2021 - 11 - 08
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 09 - 21
1
2021 - 09 - 08
1
2021 - 08 - 11
1
2021 - 08 - 02
1
2021 - 07 - 13
1
2021 - 06 - 28
1
Sector
Health technology
26
Tags
Acne
1
Adi-001
1
Al001
1
Alzheimer
4
Alzheimer's
6
Alzheimer's disease
3
Alzheimer’s
6
Approval
2
Atopic dermatitis
3
Cancer
4
Conference
3
Contract
1
Day
1
Dermatitis
3
Designation
2
Disease
4
Drug
3
Drug designation
1
Enroll
1
Extension
1
Grant
1
Granted
2
Ht-004
1
Ht-alz
5
International
2
License
1
Lung
1
Lupus
1
Molecular
1
Mrna
1
N/a
26
Nasdaq
1
Offering
1
Orphan drug
2
Partnership
2
Phase 1
3
Phase 1b
3
Phase 2b
3
Positive
4
Positive results
1
Potential
2
Pre-clinical
2
Preclinical
2
Presentation
3
Program
1
Research
2
Results
4
Roof
1
Stroke
2
Submission
1
Therapeutics
17
Therapy
1
Train
2
Treatment
3
Trial
5
Xin
2
Entities
Hoth therapeutics, inc.
26
Symbols
HOTH
26
Exchanges
Nasdaq
26
Crawled Date
2022 - 09 - 20
1
2022 - 09 - 06
1
2022 - 08 - 12
1
2022 - 06 - 29
1
2022 - 06 - 09
1
2022 - 04 - 19
1
2022 - 04 - 14
1
2022 - 04 - 12
1
2022 - 04 - 01
1
2022 - 03 - 11
1
2022 - 02 - 07
1
2022 - 01 - 31
1
2022 - 01 - 04
1
2021 - 12 - 21
1
2021 - 12 - 08
1
2021 - 11 - 30
1
2021 - 11 - 16
1
2021 - 11 - 08
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 09 - 21
1
2021 - 09 - 08
1
2021 - 08 - 11
1
2021 - 08 - 02
1
2021 - 07 - 13
1
2021 - 06 - 28
1
Crawled Time
12:00
3
12:15
2
12:20
3
13:00
8
13:15
1
13:30
2
14:00
2
15:00
1
17:00
2
18:00
2
Source
alteritytherapeutics.com
65
apyxmedical.com
47
contravir.com
39
feed.businesswire.com
38
investor.alkermes.com
92
investor.assemblybio.com
44
investor.aveooncology.com
40
investors.biomarin.com
75
investors.phiopharma.com
35
ir.akerotx.com
45
ir.anaptysbio.com
30
ir.ateapharma.com
32
ir.auriniapharma.com
65
ir.biolinerx.com
35
ir.check-cap.com
29
ir.cyclerion.com
32
ir.kalvista.com
85
ir.therapeuticsmd.com
44
ir.vaccinex.com
33
ir.viveve.com
58
ir.voyagertherapeutics.com
29
ir.zynerba.com
27
jaguarhealth.gcs-web.com
189
mdxhealth.com
111
ocutx.gcs-web.com
32
spacfeed.com
1037
www.achievelifesciences.com
30
www.admabiologics.com
53
www.allogene.com
70
www.aquestive.com
36
www.arcadiabio.com
41
www.atyrpharma.com
33
www.biospace.com
28311
www.brainsway.com
208
www.catalent.com
30
www.celyad.com
38
www.clinuvel.com
105
www.crinetics.com
49
www.curevac.com
48
www.electromed.com
42
www.fatetherapeutics.com
150
www.fda.gov
152
www.globenewswire.com
25442
www.igcinc.us
36
www.inovio.com
30
www.inventivapharma.com
55
www.invobioscience.com
34
www.kuraoncology.com
34
www.modeln.com
46
www.nurixtx.com
55
www.oncocyte.com
239
www.pacb.com
29
www.ppdi.com
40
www.precisionbiosciences.com
31
www.predictmedix.com
39
www.prnewswire.com
18844
www.sutrobio.com
164
www.thermogenesis.com
53
www.vbivaccines.com
35
www.vynetherapeutics.com
114
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
source :
Ir.hoththerapeutics.com
save search
Hoth Therapeutics Announces Partnership with Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke
Published:
2022-09-20
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
-87.9%
|
O:
0.0%
H:
2.12%
C:
-2.77%
partnership
stroke
therapeutics
train
Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-004, Shows Potential to Reduce Lung Inflammation in Asthma and Allergy Disorders
Published:
2022-09-06
(Crawled : 12:20)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
-89.1%
|
O:
-2.21%
H:
2.38%
C:
-2.14%
ht-004
lung
mrna
therapeutics
potential
Hoth Therapeutics Announces Pipeline Presentation at the 2022 Sidoti Investor Conference
Published:
2022-08-12
(Crawled : 18:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
-89.7%
|
O:
1.25%
H:
0.0%
C:
-1.61%
conference
therapeutics
presentation
Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
Published:
2022-06-29
(Crawled : 18:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
182.54%
|
O:
0.58%
H:
8.04%
C:
3.15%
day
nasdaq
extension
granted
therapeutics
Hoth Therapeutics Announces Extension of Washington University Alzheimer's Mouse Model Study with Alzheimer's Therapeutic HT-ALZ
Published:
2022-06-09
(Crawled : 12:20)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
168.47%
|
O:
-1.33%
H:
2.3%
C:
-1.14%
alzheimer's
therapeutics
alzheimer’s
ht-alz
Hoth Therapeutics Announces New Pipeline Asset, HT-TBI for Stroke and Traumatic Brain Injury
Published:
2022-04-19
(Crawled : 15:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
83.21%
|
O:
-1.35%
H:
15.67%
C:
4.13%
stroke
therapeutics
train
Hoth Therapeutics, Inc. Announces Closing of $7.0 Million Underwritten Public Offering Priced At-The-Market
Published:
2022-04-14
(Crawled : 17:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
80.0%
|
O:
1.08%
H:
6.54%
C:
5.02%
offering
Hoth Therapeutics Announces Acceptance to Present HT-ALZ Proof-of-Concept Alzheimer's Disease Data at the 2022 Alzheimer's Association International Conference
Published:
2022-04-12
(Crawled : 12:20)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
11.43%
|
O:
-23.34%
H:
0.62%
C:
-10.55%
conference
disease
therapeutics
international
alzheimer's
alzheimer’s
ht-alz
Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention
Published:
2022-04-01
(Crawled : 12:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
69.08%
|
O:
1.01%
H:
1.5%
C:
-1.26%
therapeutics
presentation
international
Hoth Therapeutics Announces Orphan Drug Designation Granted to Cancer Therapeutic HT-KIT to Treat Mastocytosis
Published:
2022-03-11
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
72.39%
|
O:
-6.73%
H:
0.0%
C:
0.0%
drug
granted
therapeutics
drug designation
orphan drug
cancer
grant
designation
Hoth Therapeutics Announces Presentation of the HT-ALZ Proof-of-Concept Alzheimer's Disease Preclinical Data at the 2022 Alzheimer's Association International Conference
Published:
2022-02-07
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
105.3%
|
O:
5.28%
H:
2.48%
C:
-1.32%
alzheimer
conference
therapeutics
presentation
disease
preclinical
roof
alzheimer’s
alzheimer's disease
pre-clinical
alzheimer's
ht-alz
Hoth Therapeutics Announces the Appointment of John Cirrito, PhD and Carla Yuede, PhD to Oversee Alzheimer's Therapeutic Program as Part of Hoth Scientific Advisory Board
Published:
2022-01-31
(Crawled : 13:30)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
122.48%
|
O:
4.58%
H:
6.89%
C:
3.05%
alzheimer
program
therapeutics
alzheimer’s
alzheimer's
Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
Published:
2022-01-04
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
66.05%
|
O:
61.79%
H:
53.51%
C:
14.04%
alzheimer
therapeutics
disease
positive results
positive
results
alzheimer’s
alzheimer's disease
alzheimer's
ht-alz
Hoth Therapeutics Announces Submission of Orphan Drug Designation Request for HT-KIT to Treat Mastocytosis
Published:
2021-12-21
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
56.0%
|
O:
1.33%
H:
0.0%
C:
-2.64%
drug
therapeutics
orphan drug
submission
designation
Hoth Therapeutics Licenses Lupus Therapeutic Back to Zylö Therapeutics
Published:
2021-12-08
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
50.02%
|
O:
1.3%
H:
7.49%
C:
3.05%
license
therapeutics
lupus
Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way
Published:
2021-11-30
(Crawled : 13:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
40.37%
|
O:
0.06%
H:
4.32%
C:
-1.8%
atopic dermatitis
phase 1
dermatitis
phase 1b
trial
therapeutics
enroll
phase 2b
Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT
Published:
2021-11-16
(Crawled : 13:30)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
14.15%
|
O:
-1.95%
H:
0.0%
C:
0.0%
cancer
research
therapeutics
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Published:
2021-11-08
(Crawled : 13:15)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
6.36%
|
O:
-0.91%
H:
3.67%
C:
1.83%
cancer
contract
drug
Hoth Therapeutics Extends Partnership Agreement with REPROCELL
Published:
2021-10-19
(Crawled : 17:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
3.54%
|
O:
-0.88%
H:
10.71%
C:
0.89%
partnership
therapeutics
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients
Published:
2021-10-12
(Crawled : 14:00)
- ir.hoththerapeutics.com
HOTH
|
$1.17
220
|
Health Technology
|
1.74%
|
O:
0.0%
H:
12.17%
C:
0.87%
treatment
dermatitis
trial
approval
atopic dermatitis
xin
← Previous
1
2
Next →
Gainers vs Losers
46%
54%
Top 10 Gainers
SGBX
|
$0.26
80.43%
54M
|
Producer Manufacturing
LICN
|
$1.0
78.57%
3.3M
|
CSSE
4
|
$0.2656
74.39%
9.7M
|
Consumer Services
BRFH
4
|
$1.89
71.82%
32M
|
Manufacturing
ACON
|
$0.49
70.14%
24M
|
n/a
BOF
|
$1.95
66.67%
920K
|
MTC
|
$3.62
61.61%
790K
|
Technology Services
AMST
|
$3.22
61.0%
720K
|
Technology Services
PCSA
|
$2.28
40.74%
37M
|
Producer Manufacturing
EVA
|
$0.626
39.14%
2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.